Thinx

Reusable period underwear for menstrual health

New York City, New York, United States

About Thinx

Thinx specializes in reusable period underwear that absorbs menstrual flow and prevents leaks, providing a comfortable and sustainable alternative to traditional menstrual products like pads and tampons. Their products cater to a diverse clientele, including women, teens, and individuals who menstruate, with options available for various flow levels and personal preferences. Thinx operates primarily through a direct-to-consumer model, selling products directly on their website, which allows them to control the customer experience from selection to delivery. This approach, along with their focus on social impact initiatives such as activism and educational programs, helps build brand loyalty. Thinx is dedicated to continuous product development and emphasizes diversity and inclusion within its team, fostering a culture of creativity. The company's goal is to promote open conversations about menstruation and improve menstrual health through their innovative products.

New York City, New YorkHeadquarters
2014Year Founded
$25.8MTotal Funding
SERIES_ACompany Stage
Social Impact, Consumer GoodsIndustries
51-200Employees

Risks

Increased competition could dilute Thinx's market share in reusable period underwear.
Kimberly-Clark acquisition may alienate customers valuing Thinx's sustainability mission.
Rising digital advertising costs challenge Thinx's direct-to-consumer profitability.

Differentiation

Thinx offers reusable period underwear with innovative LeakSafe Barrier technology.
The company promotes open conversations and education about period health.
Thinx's direct-to-consumer model ensures control over the customer experience.

Upsides

Kimberly-Clark's $25M investment boosts Thinx's market presence and product development.
Thinx won Healthline's 2024 Best Period Underwear award, enhancing brand reputation.
New CEO Meghan Davis may drive growth and innovation with fresh strategies.

Funding

Total raised$25.78 M
Latest valuation$125.00 M
StageSERIES_A
SERIES A
8/31/2019
$25
$125.00 M
EARLY VC
12/31/2014
$2
$7.50 M